Technology
Health
Pharmaceutical

Indivior

$3.14
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.45 (16.73%) Today
$0.00 (0.00%) As of 4:30 PM EDT after-hours

Why Robinhood?

You can buy or sell Indivior and other stocks, options, ETFs, and crypto commission-free!

About INVVY

INDIVIOR PLC American Depositary Receipts - Sponsored, also called Indivior, is a holding company, which engages in the manufacture and distribution of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, Subutex Tablet, and Sublocade Injection. Read More The company was founded on September 26, 2014 and is headquartered in Slough, the United Kingdom. INVVY is listed on the Pink Current market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com).

Employees
915
Headquarters
Slough, Berkshire
Founded
2014
Market Cap
392.76M
Price-Earnings Ratio
1.56
Dividend Yield
Average Volume
19.94K
High Today
$3.15
Low Today
$2.69
Open Price
$2.69
Volume
90.72K
52 Week High
$22.26
52 Week Low
$1.98

Collections

Technology
Health
Pharmaceutical
2014 IPO
UK
Europe

INVVY News

Yahoo FinanceJun 21

Pawar Law Group Reminds Investors of June 24 Deadline in Securities Class Action Lawsuit Against Indivior PLC – INVVY

639

More INVVY News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.